Key result
The synthetic prostaglandin analog 9,11-azoprosta-5,13-dienoic acid potently inhibited human platelet thromboxane synthetase and antagonized platelet aggregation induced by PGH2 or arachidonic acid.
Why the study?
Does 9,11-azoprosta-5,13-dienoic acid inhibit thromboxane synthetase and prevent aggregation in human platelets?
Does 9,11-azoprosta-5,13-dienoic acid inhibit thromboxane synthetase and prevent aggregation in human platelets?
The study provides mechanistic evidence that PGH2 must be converted to thromboxane A2 to induce human platelet aggregation, using a novel thromboxane synthetase inhibitor.
Answers are grounded in this paper and cite their sources.
May inhibit platelet aggregation via thromboxane synthetase blockade in vitro; leaves open clinical antithrombotic utility.
The synthetic prostaglandin analog 9,11-azoprosta-5,13-dienoic acid (azo analog I) has been found to be a potent inhibitor of human platelet thromboxane synthetase by three independent analytical methods: electron-capture gas chromatography, radioisotopic thin-layer chromatography, and radioimmunoassay. In the presence of azo analog I, human platelet aggregation induced by either the prostaglandin endoperoxide PGH2 or arachidonic acid was antagonized. The addition of azo analog I shifted the transformation of endoperoxides away from thromboxane synthesis and toward prostaglandin E2 synthesis. The specificity of azo analog I is demonstrated by its selective inhibition of the second wave of either ADP- or epinephrine-induced platelet aggregation. These data indicate that PGH2 must be converted to thromboxane A2 in order to induce human platelet aggregation.
No takes yet. Share an insight, caveat, or question.
Gorman et al. (1977) studied this question. 9,11-azoprosta-5,13-dienoic acid (azo analog I) was evaluated on Inhibition of human platelet thromboxane synthetase and platelet aggregation. The synthetic prostaglandin analog 9,11-azoprosta-5,13-dienoic acid potently inhibited human platelet thromboxane synthetase and antagonized platelet aggregation induced by PGH2 or arachidonic acid.
Synapse has enriched 10 related papers. Consider them for comparative context: